APA (7th ed.) Citation

KJ, M., MJ, C., DW, L., AG, M., C, B., CP, R., . . . PB, P. (2023). Cognitive outcomes at age 3 years in children with fetal exposure to antiseizure medications (MONEAD study) in the USA: A prospective, observational cohort study. The Lancet. Neurology, 22(8), 712. https://doi.org/10.1016/S1474-4422(23)00199-0

Chicago Style (17th ed.) Citation

KJ, Meador, et al. "Cognitive Outcomes at Age 3 Years in Children with Fetal Exposure to Antiseizure Medications (MONEAD Study) in the USA: A Prospective, Observational Cohort Study." The Lancet. Neurology 22, no. 8 (2023): 712. https://doi.org/10.1016/S1474-4422(23)00199-0.

MLA (9th ed.) Citation

KJ, Meador, et al. "Cognitive Outcomes at Age 3 Years in Children with Fetal Exposure to Antiseizure Medications (MONEAD Study) in the USA: A Prospective, Observational Cohort Study." The Lancet. Neurology, vol. 22, no. 8, 2023, p. 712, https://doi.org/10.1016/S1474-4422(23)00199-0.